Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Obstet Gynecol. 2014 Jan;123(1):141–148. doi: 10.1097/AOG.0000000000000057

Table 1.

Weighted Prevalence Rates of Pelvic Floor Disorders by Demographic Categories in Nonpregnant U.S. Women (N = 7924)

Weighted Prevalence, % (95% Confidence Interval)

Variable No. of Women Pelvic Organ Prolapse (n = 7071) Fecal Incontinence (n = 7046) Urinary Incontinence (n= 7142) One or More Pelvic Floor Disorder (n = 7924)*

Overall 2.9 (2.5, 3.4) 9.4 (8.6, 10.2) 17.1 (15.8, 18.4) 25.0 (23.6, 26.3)

Age, years
 20–29 1128 0.5 (0.3, 1.1) 2.6 (1.7, 3.9) 3.5 (2.6, 4.9) 6.3 (5.0, 7.8)

 30–39 1117 2.1 (1.4, 3.2) 4.3 (3.3, 5.6) 9.2 (7.5, 11.2) 13.6 (11.7, 15.7)

 40–49 1318 2.3 (1.5, 3.5) 8.8 (7.0, 10.9) 15.0 (12.7, 17.6) 23.4 (20.5, 26.6)

 50–59 1085 4.0 (2.8, 5.7) 11.0 (9.3, 12.9) 22.4 (19.1, 26.1) 31.6 (28.3, 35.1)

 60–69 1193 5.1 (3.4, 7.6) 16.5 (13.7, 19.6) 24.7 (21.0, 28.8) 38.5 (33.8, 43.3)

 70–79 805 4.3 (2.8, 6.6) 14.3 (11.5, 17.6) 29.7 (26.0, 33.6) 39.6 (35.6, 43.8)

 ≥80 496 4.0 (2.5, 6.5) 21.0 (16.9, 25.8) 38.2 (33.7, 43.0) 52.7 (48.1, 57.2)

 p value <0.001 <0.001 <0.001 <0.001

Race/Ethnicity
 Hispanic, Mexican American 1267 5.3 (4.1, 6.8) 6.3 (4.8, 8.1) 17.2 (14.9, 19.6) 24.0 (21.3, 26.8)

 Hispanic, Other 662 4.5 (2.9, 7.1) 6.8 (5.3, 8.8) 13.1 (10.8, 15.9) 20.0 (17.4, 22.9)

 Non-Hispanic White 3475 2.7 (2.2, 3.4) 10.2 (9.1, 11.30 18.2 (16.7, 20.0) 26.4 (24.6, 28.2)

 Non-Hispanic black 1445 2.2 (1.5, 3.2) 7.9 (6.5, 9.6) 12.8 (11.3, 14.4) 20.0 (17.8, 22.5)

 Other, including multi-racial 293 2.1 (0.8, 5.5) 8.7 (5.1, 14.5) 13.9 (10.0, 19.1) 22.6 (17.1, 29.2)

P value 0.01 0.04 <0.001 0.002

Education
 <High school 1960 4.8 (3.8, 6.1) 12.0 (10.2, 14.0) 23.8 (21.7, 26.1) 32.6 (30.3, 35.1)

 High school 1675 3.1 (2.1, 4.5) 9.3 (7.8, 10.9) 18.4 (16.3, 20.7) 27.0 (25.0, 23.7)

 >High school 3496 2.2 (1.7, 2.8) 8.6 (7.4, 10.0) 14.5 (13.0, 16.1) 21.8 (20.0, 23.70

P value <0.001 0.03 <0.001 <0.001

Poverty income ratio
 <1 1369 4.3 (3.3, 5.4) 9.3 (7.5, 11.5) 19.6 (17.2, 22.3) 27.3 (24.6, 30.3)

 1–2 1832 3.7 (2.7, 5.1) 11.4 (10.0, 13.1) 19.2 (17.0, 21.6) 27.9 (25.7, 30.2)

 >2 3941 2.4 (1.9, 3.0) 8.8 (7.8, 9.9) 16.0 (14.6, 17.4) 23.6 (22.2, 25.2)

 p value 0.005 0.02 0.001 <0.001

BMI
 <25.0 2181 2.0 (1.4, 2.7) 7.5 (6.4, 8.8) 10.3 (8.9, 11.9) 17.8 (15.7, 19.5)

 25.0 – 29.9 2059 3.5 (2.5, 4.7) 9.3 (7.8, 11.1) 18.1 (16.1, 20.2) 26.5 (24.3, 28.8)

 ≥30.0 2902 3.4 (2.7, 4.2) 11.2 (9.5, 13.2) 22.9 (20.6, 25.5) 31.1 (28.5, 33.7)

P value 0.02 0.007 <0.001 <0.001

Self-reported conditions/comorbid diseases (cumulative count)

 0 3445 1.9 (1.5, 2.8) 5.6 (4.6, 6.9) 9.7 (8.7, 10.8) 15.6 (14.4, 16.8)

 1 1938 3.7 (2.7, 5.1) 9.4 (8.2, 10.9) 20.3 (17.9, 22.9) 28.5 (26.0, 31.1)

 2 1017 4.2 (3.1, 5.8) 15.8 (13.4, 18.5) 27.3 (23.7, 31.2) 39.9 (36.5, 43.5)

 ≥3 708 4.5 (3.2, 6.5) 23.0 (18.5, 28.2) 37.2 (33.3, 42.2) 50.1 (45.6, 54.6)

P value <0.001 <0.001 <0.001 <0.001

Hysterectomy

 No 4621 2.3 (1.9, 2.7) 8.0 (7.2, 8.9) 14.7 (13.5, 16.0) 21.8 (20.5, 23.1)

 Yes 1717 5.4 (4.0, 7.3) 16.6 (14.6, 18.8) 29.5 (26.8, 32.3) 42.2 (39.1, 45.4)

P value <0.001 <0.001 <0.001 <0.001

Parity
 0 1018 0.6 (0.3, 1.6) 4.6 (3.4, 6.3) 7.9 (6.4, 9.8) 11.5 (9.6, 13.8)

 1 784 1.4 (0.7, 2.9) 10.3 (7.6, 13.7) 11.8 (9.4, 14.9) 21.1 (17.8, 24.9)

 2 1450 3.2 (2.3, 4.5) 8.3 (6.7, 10.1) 15.6 (13.4, 18.2) 23.8 (21.0, 26.8)

 3 1416 3.2 (2.2, 4.5) 11.1 (9.1, 13.4) 20.5 (18.0, 23.3) 28.7 (25.9, 31.6)

 ≥4 2462 4.5 (3.7, 5.6) 11.8 (10.2, 13.5) 23.9 (21.7, 26.3) 33.6 (30.9, 36.5)

P value <0.001 <0.001 <0.001 <0.001

Mode of delivery

 Never pregnant 1018 0.6 (0.3, 1.3) 4.6 (3.4, 6.3) 7.9 (6.4, 9.8) 11.5 (9.6, 13.8)

 Vaginal delivery 4527 4.0 (3.3, 4.8) 11.5 (10.5, 12.6) 20.6 (18.9, 22.4) 30.4 (28.6, 32.3)

 Cesarean delivery 723 1.9 (1.1, 3.3) 6.4 (4.6, 8.8) 12.7 (10.4, 15.4) 18.4 (15.7, 21.5)

 Vaginal and cesarean deliveries 571 2.3 (1.2, 4.1) 7.2 (4.3, 11.7) 19.5 (15.5, 24.1) 25.3 (19.9, 31.5)

P value <0.001 <0.001 <0.001 <0.001
*

Sample size higher for more than one pelvic floor disorder than for pelvic organ prolapse (POP), fecal incontinence (FI), or urinary incontinence (UI) alone due to overlap for POP, FI, UI or a combination of these.

All P values calculated using chi-square analysis with the appropriate sampling weights.